Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 13/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 12/20 | 0.40 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | MEF2D | Q14814 | 1/20 | 0.38 |
| ▸ | SIRT3 | Q9NTG7 | 9/20 | 0.38 |
| ▸ | CPB1 | P15086 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2607891 | 0.83 | SIRT1 (0.44) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL12410205 | 0.82 | SIRT1 (0.49) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL13311516 | 0.82 | SIRT2 (0.45) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL12583936 | 0.80 | SIRT1 (0.47) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL14870358 | 0.80 | SIRT2 (0.49) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL2607889 | 0.79 | SIRT2 (0.45) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL277854 | 0.79 | SIRT2 (0.48) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL11955606 | 0.77 | SIRT1 (0.42) | SIRT2SIRT1SIRT6HDAC4EP300 | |
| SCHEMBL25176590 | 0.77 | KMT2A (0.45) | SIRT2SIRT1SIRT3 | |
| SCHEMBL25176589 | 0.77 | KMT2A (0.45) | SIRT2SIRT1SIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110171166-A1 | POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES | NEKTAR THERAPEUTICS | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171166-A1 | POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES | SOST, PTMS, ALPP | SIRT2 2572/4885SIRT1 1581/4885SIRT6 1997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.